CD8A and neoplasm: We found that compared with high-risk patients, CD8+ T cells, DCs, Macrophages, and tumor-infiltrating lymphocytes (TIL) cells in the low-risk patients were abundant in infiltration and functionally active, suggesting that high tumor immunological infiltration has a better prognosis.